Ginkgo Bioworks
Ginkgo Bioworks is a biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.
All edits by David Hao
Edits on 1 May, 2019
Edits made to:
Article (+13/-13 characters)
Article
On July 16th, 2014 Ginkgo Bioworks received $120K in seed funding from Y Combinator, TSVC, CRCM venturesCRCM ventures, 11.2 Capital, Farzad Nazem, Todd Corenson, and David Spector.
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.